Pharvaris N.V. Ordinary Shares Share Price
NASDAQ: PHVSHealthcare
Live Pharvaris N.V. Ordinary Shares Share Price Chart
O H L
Pharvaris N.V. Ordinary Shares Performance Overview
Days Range
▼
$37.89Low
$37.89High
Markets Today
| Previous Close | $38.00 |
|---|---|
| Open | $37.89 |
| Volume | 22,861 |
| Day's Range | $37.89 - $37.89 |
| 52W Range | $20.65 - $43.25 |
| Market Cap | $2.64 B |
Historical Performance
| 1M Returns | +5.26 |
|---|---|
| 3M Returns | +15.85 |
| 6M Returns | +45.20 |
| 1Y Returns | +54.85 |
| 5Y Returns | +109.33 |
| 10Y Returns | NA |
Pharvaris N.V. Ordinary Shares Fundamentals
| Market Cap | $2.64 B |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $0.00 |
| ROE TTM | -0.65 |
| EPS TTM | $-2.99 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 7.64 |
| EBITDA | $-198.76 M |
| Profit Margin | N/A |
| Market Cap | $2.64 B |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $0.00 |
| ROE TTM | -0.65 |
| EPS TTM | $-2.99 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 7.64 |
| EBITDA | $-198.76 M |
| Profit Margin | N/A |
Pharvaris N.V. Ordinary Shares Profit & Loss
Quarterly
| Total Revenue + |
| Gross Profit + |
| Operating Income |
| EBITDA |
| Interest Expense |
| Depreciation |
| Income Before Tax |
| Income Tax Expense |
| Net Income + |
| Net Profit Margin |
Pharvaris N.V. Ordinary Shares Financials Balance Sheet In USD
Quarterly
| Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 | |
|---|---|---|---|---|---|
| Share Capital | $4.52 M | $4.35 M | $6.94 M | $6.79 M | $9.18 M |
| Reserve & Surplus | -$99.55 M | -$176.12 M | -$293.98 M | -$418.43 M | -$680.34 M |
| Non-Current Liabilities | $171.43 K | $267.54 K | $48.16 K | $664.97 K | $676.49 K |
| Current Liabilities | $7.94 M | $19.55 M | $16.14 M | $23.91 M | $34.73 M |
| Total Liabilities | $8.12 M | $19.82 M | $16.19 M | $24.57 M | $35.41 M |
| Fixed Assets | $122.92 K | $207.53 K | $247.27 K | $694.06 K | $753.79 K |
| Current Assets | $240.58 M | $178.97 M | $439.34 M | $300.68 M | $350.35 M |
| Total Assets | $241.18 M | $179.92 M | $440.74 M | $303.19 M | $353.69 M |
Pharvaris N.V. Ordinary Shares Cash Flow
Quarterly
| Net Income |
| Operating Cash Flow |
| Investing Cash Flow |
| Financing Cash Flow |
| Change in Cash |
Pharvaris N.V. Ordinary Shares Return Calculator
The Pharvaris N.V. Ordinary Shares stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$20,430
Invested Amount$10,000
Est. Returns$10,430
About Pharvaris N.V. Ordinary Shares
Pharvaris NV is a late-stage biopharmaceutical company which is engaged in developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks. By directly pursuing this clinically therapeutic target with novel small molecules, With positive data in both Phase 2 prophylaxis and studies in HAE, Pharvaris is developing deucrictibant. Pharvaris is currently enrolling a pivotal Phase 3 study for the treatment of HAE attacks and plans to initiate a pivotal Phase 3 study of deucrictibant for the prevention of HAE attacks. The company is also running open-label extension studies in both on-demand (RAPIDe-2) and prophylactic (CHAPTER-4) settings to collect long-term safety and efficacy data in HAE patients.
Popular Stocks
FAQs
What is the share price of Pharvaris N.V. Ordinary Shares today?
Pharvaris N.V. Ordinary Shares (PHVS) share price as of September 18, 2026 is $37.08. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Pharvaris N.V. Ordinary Shares?
Yes, Indian Investors can invest in the Pharvaris N.V. Ordinary Shares (PHVS) Share by opening an international trading account with Angel One.
How can I purchase Pharvaris N.V. Ordinary Shares shares in India?
Purchasing Pharvaris N.V. Ordinary Shares (PHVS) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Pharvaris N.V. Ordinary Shares (PHVS) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Pharvaris N.V. Ordinary Shares?
Yes, you can purchase fractional shares of Pharvaris N.V. Ordinary Shares (PHVS) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Pharvaris N.V. Ordinary Shares?
The market capitalization of Pharvaris N.V. Ordinary Shares on September 18, 2026, is $2.64 B.
In which sector Pharvaris N.V. Ordinary Shares belongs?
Pharvaris N.V. Ordinary Shares operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in Pharvaris N.V. Ordinary Shares stocks?
In order to invest in Pharvaris N.V. Ordinary Shares (PHVS) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
